Literature DB >> 26846719

Methamphetamine-, d-Amphetamine-, and p-Chloroamphetamine-Induced Neurotoxicity Differentially Effect Impulsive Responding on the Stop-Signal Task in Rats.

Teri M Furlong1, Lee S Leavitt2, Kristen A Keefe2, Jong-Hyun Son2.   

Abstract

Abused amphetamines, such as d-amphetamine (AMPH) and methamphetamine (METH), are highly addictive and destructive to health and productive lifestyles. The abuse of these drugs is associated with impulsive behavior, which is likely to contribute to addiction. The amphetamines also differentially damage dopamine (DA) and serotonin (5-HT) systems, which regulate impulsive behavior; therefore, exposure to these drugs may differentially alter impulsive behavior to effect the progression of addiction. We examined the impact of neurotoxicity induced by three amphetamines on impulsive action using a stop-signal task in rats. Animals were rewarded with a food pellet after lever pressing (i.e., a go trial), unless an auditory cue was presented and withholding lever press gained reward (i.e., a stop trial). Animals were trained on the task and then exposed to a neurotoxic regimen of either AMPH, p-chloroamphetamine (PCA), or METH. These regimens preferentially reduced DA transporter levels in striatum, 5-HT transporter levels in prefrontal cortex, or both, respectively. Assessment of performance on the stop-signal task beginning 1 week after the treatment revealed that AMPH produced a deficit in go-trial performance, whereas PCA did not alter performance on either trial type. In contrast, METH produced a deficit in stop-trial performance (i.e., impulsive action) but not go-trial performance. These findings suggest that the different neurotoxic consequences of substituted amphetamines are associated with different effects on inhibitory control over behavior. Thus, the course of addiction and maladaptive behavior resulting from exposure to these substances is likely to differ.

Entities:  

Keywords:  Amphetamine; Behavioral inhibition; Dopamine; Impulsive action; Serotonin; Stop-signal task

Mesh:

Substances:

Year:  2016        PMID: 26846719      PMCID: PMC4821695          DOI: 10.1007/s12640-016-9605-9

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  60 in total

1.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

2.  A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Authors:  Paul J Fletcher; Catherine C Tenn; Judy Sinyard; Zoë Rizos; Shitij Kapur
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

Review 3.  Methamphetamine influences on brain and behavior: unsafe at any speed?

Authors:  John F Marshall; Steven J O'Dell
Journal:  Trends Neurosci       Date:  2012-06-16       Impact factor: 13.837

4.  Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.

Authors:  Annabelle M Belcher; Steven J O'Dell; John F Marshall
Journal:  Neuropsychopharmacology       Date:  2005-11       Impact factor: 7.853

5.  Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders.

Authors:  Catharine A Winstanley; David E H Theobald; Jeffrey W Dalley; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

6.  Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Authors:  Y Sekine; M Iyo; Y Ouchi; T Matsunaga; H Tsukada; H Okada; E Yoshikawa; M Futatsubashi; N Takei; N Mori
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

7.  Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

Authors:  Paul J Fletcher; Catherine C Tenn; Zoë Rizos; Vedran Lovic; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

8.  Perseverative behavior in rats with methamphetamine-induced neurotoxicity.

Authors:  Jong-Hyun Son; James Kuhn; Kristen A Keefe
Journal:  Neuropharmacology       Date:  2012-11-14       Impact factor: 5.250

9.  High impulsivity predicts the switch to compulsive cocaine-taking.

Authors:  David Belin; Adam C Mar; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  Science       Date:  2008-06-06       Impact factor: 47.728

Review 10.  An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Authors:  Andy C Dean; Stephanie M Groman; Angelica M Morales; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2012-09-05       Impact factor: 7.853

View more
  6 in total

1.  Inhibitory-control training for cocaine use disorder and contingency management for clinic attendance: A randomized pilot study of feasibility, acceptability and initial efficacy.

Authors:  Craig R Rush; Justin C Strickland; Erika Pike; Christina R Studts; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2019-12-16       Impact factor: 4.492

2.  The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.

Authors:  Yunpeng Wang; Fangyuan Yin; Hao Guo; Jing Zhang; Peng Yan; Jianghua Lai
Journal:  Int J Neuropsychopharmacol       Date:  2017-07-01       Impact factor: 5.176

3.  3D Printable Device for Automated Operant Conditioning in the Mouse.

Authors:  Raffaele Mazziotti; Giulia Sagona; Leonardo Lupori; Virginia Martini; Tommaso Pizzorusso
Journal:  eNeuro       Date:  2020-04-27

Review 4.  Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits.

Authors:  Manoranjan S D'Souza
Journal:  Front Psychiatry       Date:  2019-07-24       Impact factor: 4.157

5.  Amphetamine Neurotoxicity in PC12 Cells through the PP2A/AKT/GSK3β Pathway.

Authors:  Wenji He; Xinyu Yan; Sanqiang Pan
Journal:  Neurotox Res       Date:  2018-03-06       Impact factor: 3.911

6.  Behavioral and Serotonergic Changes in the Frontal Cortex Following Methamphetamine Self-Administration.

Authors:  Lisa M McFadden; Rebecca Cordie; Tamee Livermont; Andrew Johansen
Journal:  Int J Neuropsychopharmacol       Date:  2018-08-01       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.